Article Text

Download PDFPDF
Ethics of digital contact tracing wearables
  1. G Owen Schaefer1,
  2. Angela Ballantyne1,2
  1. 1 Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
  2. 2 Department of Primary Health Care and General Practice, University of Otago, Wellington, New Zealand
  1. Correspondence to Dr G Owen Schaefer, Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore; owen_schaefer{at}nus.edu.sg

Abstract

The success of digital COVID-19 contact tracing requires a strategy that successfully addresses the digital divide—inequitable access to technology such as smartphones. Lack of access both undermines the degree of social benefit achieved by the use of tracing apps, and exacerbates existing social and health inequities because those who lack access are likely to already be disadvantaged. Recently, Singapore has introduced portable tracing wearables (with the same functionality as a contact tracing app) to address the equity gap and promote public health. We argue that governments have an ethical obligation to ensure fair access to the protective benefits of contract tracing during the pandemic and that wearables are an effective way of addressing some important equity issues. The most contentious issues about contact tracing apps have been the potential infringements of privacy and individual liberty, especially where the use of apps or other technology (such as wearables or QR codes) is required for access to certain spaces. Here we argue that wearables, as opposed to apps alone, will make a digital contact tracing mandate more practical and explain some conditions under which such a mandate would be justified. We focus on Singapore as a case study that has recently deployed contact tracing wearables nationally, but also reference debate about wearables in Australia and New Zealand. Our analysis will be relevant to counties trialling similar portable tracing wearables.

  • confidentiality/privacy
  • information technology
  • public health ethics
  • social control of science/technology
  • COVID-19

Data availability statement

There are no data in this work

This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter @G_Owen_Schaefer

  • Contributors This paper was conceived by GOS. Its content was decided after discussion by GOS and AB, with GOS providing the initial draft and GOS and AB subsequently discussing and iterating edits and comments on subsequent drafts.

  • Funding This paper was supported in part by a grant from the Social Science Research Council (Ministry of Education, Singapore): MOE2017-SSRTG-028.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Other content recommended for you